XLO - Xilio Therapeutics, Inc.

Name: Xilio Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Classified under Biotechnology (Health Care sector), XLO's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Russo Rene	325.4K	-	-
Other	Luptakova Katarina	33.3K	-	-
CFO	Frankenfield Christopher James	24.8K	$15.9K	-
Dir	Shannon James Samuel	10.0K	$87.9K	-
VP	Brennan Kevin M.	6.4K	$4.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 26, 2026	Shannon James Samuel	Director	Buy	5,000	$8.79	$43,950.00	+100.0%	+3.8%	-
Jan 2, 2026	Brennan Kevin M.	SVP, Finance and Accounting	Sale+OE	1,826	$0.64	$1,174.48	-22.3%	-9.5%	-
Jan 2, 2026	Frankenfield Christopher James	Chief Financial Officer	Sale+OE	7,030	$0.64	$4,521.70	-22.1%	-9.5%	-
Jun 17, 2025	Shannon James Samuel	-	Buy	70,000	$0.69	$48,085.00	New	+13.0%	+1149.4%
Jun 16, 2025	Russo Rene	President and CEO	Buy	36,289	$0.68	$24,680.15	+14.8%	+9.6%	+1102.6%
Jan 2, 2025	Frankenfield Christopher James	Chief Financial Officer	Sale+OE	6,954	$0.98	$6,840.65	-35.9%	-31.7%	-37.2%
Jan 2, 2025	Brennan Kevin M.	SVP, Finance and Accounting	Sale+OE	1,803	$0.98	$1,773.61	-36.1%	-31.7%	-37.2%
Feb 8, 2024	Atlas Venture Fund Xi, L.P.53	10% Owner	Sell	1,000	$0.64	$640.00	-0.1%	+101.7%	+13.3%
Jan 12, 2024	Atlas Venture Fund Xi, L.P.53	10% Owner	Sell	4,235	$0.85	$3,600.45	-0.6%	+83.0%	+48.0%
Dec 10, 2021	Bain Capital Life Sciences Investors, LLC48	10% Owner	Buy	42,469	$9.66	$410,161.39	+1.5%	-24.1%	-77.6%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC